Author: Supriya Desai, Sciformix Corporation
The importance of pharmacovigilance (PV) as a science, critical to both effective patient care in clinical practice and public health is growing. Patient-centeredness and patient safety have emerged as core elements in today’s interactive and responsive healthcare systems. As patients take more interest in their health and healthcare, they support the maxim of ‘‘Nothing about me, without me’’ and expect caregivers to engage in shared decision making, so that the patients’ voice is always included.
Patients usually report adverse drug reactions (ADRs) to their doctors. However, since only 5% of doctors are estimated to participate in PV, traditional mechanisms may not be efficient in ensuring adequate safety reporting. Data from studies indicate that systems which enable direct recording of patient concerns may identify new drug safety signals earlier than professional reporting systems alone1. This emphasises that the patients’ role in actively reporting ADRs is key to building a better PV ecosystem.